LRRK2 and Parkinson disease: One limitation of this study is that LRRK2 G2019S KI mice do not spontaneously develop Parkinsonism; therefore, it is imperative to develop a PD model with the LRRK2 G2019S mutation and further evaluate its susceptibility to tumorigenesis in the future.